Home » Topics » Regulatory » Patents

Patents
RSS

DuPont Merck develops novel CRF antagonists

Dec. 5, 1997

Vitronectin receptor antagonists described by Hoechst

Dec. 4, 1997

Bayer develops CETP inhibitors

Dec. 4, 1997

Diagnostic use of specific sigma2 ligands described by Wake Forest University

Dec. 4, 1997

MDR modulators prepared at Janssen

Dec. 4, 1997

Antiviral thiazolidines and thiazolidinones from INSERM

Dec. 4, 1997

Neurogen patents new dopamine receptor subtype-specific ligands

Dec. 3, 1997

VEGF receptor tyrosine kinase inhibitors under development at Zeneca

Dec. 3, 1997

Compounds for 5-HT-mediated disorders from Astra

Dec. 3, 1997

CoCensys/Acea reveal new AMPA receptor antagonists/positive modulators

Dec. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...